E30073 SURTIME


Protocolnummer:
NCT01099423

Ziekenhuizen:
AMC Amsterdam
Jeroen Bosch ziekenhuis Den Bosch
NKI / A.v.L ziekenhuis Amsterdam
Universitair Medisch Centrum Groningen
Universitair Medisch Centrum Utrecht
VU Medisch Centrum Amsterdam

Titel:
Randomized Phase III Trial Comparing Immediate Versus Deferred Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma

Behandeling:
Immeadiate versus deferred (sunitinib treatment) nephrectomy

Stadium:

Belangrijkste in/exclusiecriteria:
In: Histologically confirmed metastatic Renal Cell Cancer of clear-cell subtype with a resectable asymptomatic in situ primary Histology “clear-cell” subtype: If the diagnosis is not established patients need to undergo a transcutaneous tru-cut needle biopsy of the primary tumor, Resectable tumor: primary tumor must be resectable and resectability should not be doubtful at entry Ex: Patients for whom complete surgical remission can be achieved by removing metastatic sites at nephrectomy or during an additional intervention, Patients with symptomatic primary necessitating nephrectomy, - Patients with previous partial or total nephrectomy, Patients with unresectable bulky locoregional lymph node metastases larger than the primary tumor

Contactpersoon:
Dr. A. Bex

Alle niercelcarcinoom trials